Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    Regularly updated with the latest evidence on invasive fungal infections, the most recent
    update to be added to the AIKN-IFI summarises the findings from a consensus of
    international experts on the management of intra-abdominal candidiasis.

    Healthcare professionals can view the recommendations for free; it can be found in the
    guidelines section of this resource.

    March 2015 MYC/15/0019/EUa

  • ,

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    Recently updated with ISICEM 2015 presentations, data from the largest ever European
    clinician consensus report, as well as key perspectives on Clostridium difficile infection
    The Anti-Infectives Knowledge Network shares expertise and experience in the area of

    This educational resource is an initiative by Astellas Pharma EMEA. Please remember
    to return often to read the news, clinical insights, and essential information from the
    latest anti-infectives congresses.

    March 2015 FDX/15/0024/EUb

  • ,

    New Therapy Focus area for
    type 2 diabetes launched

    This free resource has recently launched on epgonline.org containing information
    for healthcare professionals based in Europe on the use of incretin‐insulin treatment
    combinations for type 2 diabetes. Explore five informative sections focused on the role
    emerging incretin‐based therapies can play in the long‐term treatment and management of
    type 2 diabetes.

  • ,Whats's New Diabetes Knowledge Centre Relaunch

    Updated Type 2 Diabetes Mellitus Knowledge Centre

    Explore new information added to the diagnosis and treatment sections of the
    Type 2 Diabetes Mellitus Knowledge Centre with recommendations on the appropriate
    management of the condition. A brand new guidelines section is also available,
    containing the latest recommendations from ADA, EASD and NICE.

  • ,What's New Hypogonadism

    Hypogonadism Knowledge Centre

    epgonline.org’s Hypogonadism Knowledge Centre features a publications digest section,
    regularly updated with analysis and comment on recent scientific articles related to male

    Found within the Men’s Health/Andrology disease topic homepage, users can also access
    information on the prevalence, diagnosis and available treatment options for male

Latest News

AstraZeneca, MedImmune and Celgene collaborate on development and commercialisation of MEDI4736 in blood cancers.


AstraZeneca and MedImmune, the Company’s global biologics research and development arm, announced that they have entered into an exclusive collaboration agreement with Celgene Corporation, a global leader in haematological cancers, for the ...

AstraZeneca,MedImmune and Innate Pharma to combine MEDI4736 and IPH 2201 in cancer treatments.


AstraZeneca and MedImmune, the Company’s global biologics research and development arm, announced that they have entered into a collaboration to accelerate and broaden the development of Innate Pharma SA’s proprietary anti-NKG2A antibody, IPH 2201, ...

Final results of Phase III trial of RTS,S Malaria vaccine published in The Lancet-Glaxo Smith Kline


Final results from a large-scale Phase III trial of RTS,S malaria vaccine candidate, from Glaxo Smith Kline, including the impact of a booster dose, have been published in The Lancet and show that the vaccine helped protect children and infants from ...

Data from Phase III trial of MK 5172 + MK 8742 (grazoprevir/elbasvir) in HCV published-Merck Inc


Merck Inc has announced the first data from the ongoing C-EDGE pivotal Phase III clinical trial program evaluating the investigational once-daily tablet MK 5172+MK 8742 (grazoprevir/elbasvir) in patients with or without cirrhosis who are infected ...

Rhopressa fails to meet endpoint in Phase III trial for Glaucoma or Ocular Hypertension- Aerie Pharmaceuticals


Aerie Pharmaceuticals has reported the results of its first Phase III registration trial (Rocket 1) for Rhopressa, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma ...

CHMP recommends Opdivo (nivolumab)for metastatic melanoma.-BMS


Bristol-Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Opdivo (nivolumab), a PD-1 immune checkpoint inhibitor, be ...

Celgene fulfills FDA accelerated approval requirements for Pomalyst/Imnovid (pomalidomide)for multiple myeloma.


Celgene Corporation has announced it has fulfilled the accelerated approval requirements for Pomalyst (pomalidomide) based on results from MM-003, an international phase III study of Pomalyst plus low-dose dexamethasone versus high-dose ...

Recent Updates


Clinical Guidelines

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis


EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Medical Journals

Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells.

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer

Liraglutide and obesity: a review of the data so far.

MAP Kinase Phosphatase 2 Regulates Macrophage-Adipocyte Interaction.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors